Renaissance Technologies - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$673,000
+32.0%
1,076,683
+12.0%
0.00%0.0%
Q3 2020$510,000
-9.6%
960,900
+16.7%
0.00%
Q2 2020$564,000
+7.2%
823,143
+17.4%
0.00%
-100.0%
Q1 2020$526,000
-47.8%
701,243
+5.2%
0.00%0.0%
Q4 2019$1,007,000
+66.7%
666,868
+63.4%
0.00%0.0%
Q3 2019$604,000
+230.1%
408,162
+188.3%
0.00%
Q2 2019$183,000
-34.4%
141,555
+32.3%
0.00%
Q1 2019$279,000
-54.2%
106,968
+151.7%
0.00%
-100.0%
Q4 2015$609,00042,5000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders